Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia

被引:16
|
作者
Tadege M. [1 ]
机构
[1] Department of Statistics, Injibara University, Injibara Amhara
关键词
ART; HIV; Survival; TB;
D O I
10.1186/s13104-018-3863-y
中图分类号
学科分类号
摘要
Objective: The purpose of this study was to identify the major risk factors, which contributed to shortened survival time to death of HIV patients on antiretroviral therapy. Six-hundred HIV patients were included from two hospitals and six health centers record from January 2003 to December 2017. Kaplan-Meier and Cox proportional hazard model were implemented. Results: From the Kaplan-Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P =.000), occupation (P =.027), and WHO clinical stage (P =.012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Antiretroviral therapy of HIV-infected patients
    Gölz, J
    MEDIZINISCHE WELT, 1999, 50 (06): : 223 - 229
  • [22] Incidence of opportunistic infections and its predictors among HIV/AIDS patients on antiretroviral therapy in Gondar University Comprehensive and Specialized Hospital, Ethiopia
    Dagnaw, Mequanente
    Fekadu, Haileab
    Egziabher, Adhanom Gebre
    Yesfue, Tesfaye
    Indracanti, Meera
    Tebeje, Alemu
    HIV RESEARCH & CLINICAL PRACTICE, 2023, 24 (01)
  • [23] Causes of death of HIV-infected patients in the highly active antiretroviral therapy era
    Roca, B
    Rovira, RE
    Perez, AP
    Cabestany, B
    ANTIVIRAL THERAPY, 2003, 8 (04) : L82 - L82
  • [24] Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
    Detels, R
    Muñoz, A
    McFarlane, G
    Kingsley, LA
    Margolick, JB
    Giorgi, J
    Scharager, LD
    Phair, JP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17): : 1497 - 1503
  • [25] Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy
    Masia, Mar
    Padilla, Sergio
    Alvarez, Debora
    Lopez, Juan C.
    Santos, Ignacio
    Soriano, Vicente
    Hernandez-Quero, Jose
    Santos, Jesus
    Tural, Cristina
    del Amo, Julia
    Gutierrez, Felix
    AIDS, 2013, 27 (02) : 181 - 189
  • [26] Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia
    Ayele Tiyou
    Tefera Belachew
    Fisehaye Alemseged
    Sibhatu Biadgilign
    AIDS Research and Therapy, 7
  • [27] Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia
    Tiyou, Ayele
    Belachew, Tefera
    Alemseged, Fisehaye
    Biadgilign, Sibhatu
    AIDS RESEARCH AND THERAPY, 2010, 7
  • [28] Neuropathy complication of antiretroviral therapy in HIV/AIDS patients
    Winias, Saka
    Radithia, Desiana
    Savitri Ernawati, Diah
    ORAL DISEASES, 2020, 26 : 149 - 152
  • [29] Immunological and clinical progress of HIV/AIDS patients on antiretroviral therapy at a health center in Addis Ababa, Ethiopia
    Teni, Fitsum Sebsibe
    Worku, Fikru
    ARCHIVES OF PHARMACY PRACTICE, 2014, 5 (01) : 14 - 18
  • [30] Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania
    Semvua, Seleman Khamis
    Orrell, Catherine
    Mmbaga, Blandina Theophil
    Semvua, Hadija Hamis
    Bartlett, John A.
    Boulle, Andrew A.
    PLOS ONE, 2017, 12 (12):